Dare Bioscience, Inc. Gain (Loss) on Termination of Lease
Dare Bioscience, Inc. (DARE) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2024-03-28
- Dare Bioscience, Inc. gain (loss) on termination of lease for the quarter ending 2022-09-30 was $46.00K.
- Dare Bioscience, Inc. gain (loss) on termination of lease for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Dare Bioscience, Inc. gain (loss) on termination of lease for fiscal 2022 was $46.48K.
- Dare Bioscience, Inc. gain (loss) on termination of lease for fiscal 2021 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-12-31 | $46.48K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $46.00K 10-Q · filed 2022-11-10 | $46.48K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |